BioCentury
ARTICLE | Company News

Avantogen, Endocyte deal

June 20, 2005 7:00 AM UTC

ACU will receive an undisclosed milestone payment from Endocyte. The payment will be triggered by ACU's submission of a drug master file to FDA for its GPI-0100 vaccine adjuvant. Endocyte is running a...